Quest Laboratories Board of Directors
Get the latest insights into the leadership at Quest Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Anil Kumar Sabarwal | Chairman & Managing Director |
| Ms. Tejaswini Sabarwal | Whole Time Director |
| Mr. Vinayak Sabarwal | Executive Director |
| Mr. Gautam Chand Kothari | Independent Director |
| Mr. Amit Ramesh Chandak | Independent Director |
| Mr. Basant Lal Menghwani | Independent Director |
Quest Laboratories Share price
QUESTLAB
99.2
0.20 (0.20%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:31 IST
BUYSELL
Today's High
99.75
Today's Low
99.00
52 Week Low
75.15
52 Week High
160.00
The current prices are delayed, login to your account for live prices
LoginQuest Laboratories FAQs
The board at Quest Laboratories consists of experienced professionals, including Mr. Anil Kumar Sabarwal , Ms. Tejaswini Sabarwal , and others, overseeing the company’s strategic and corporate governance.
Directors at Quest Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Anil Kumar Sabarwal is the current chairman at Quest Laboratories.
Executive directors at Quest Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Quest Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Quest Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.